Cambridge-headquartered Cycle Pharmaceuticals has launched PHYRAGO, its first oncology product, in the US where it has ...

Railpen, which is developing some of the most important property schemes ever seen in Cambridge, has called for the ...

Cambridge coding & marking technology specialist Domino is playing a key role in providing connected pharmaceutical packaging ...

Cambridge headquartered pharma company Bicycle Therapeutics saw its share price on Nasdaq in the US start to nudge north as ...

There is no doubt that Rachel Reeves’ first Budget in October 2024 drew sharp intakes of breath, as we listened to the tax ...

PEM, Cambridge’s largest independent firm of accountants, tax and business advisers, is celebrating a remarkable milestone in ...

SoftBank Robotics has joined forces with Cambridge Cluster avatar pioneer SKC Studios to target opportunities in the ...

Cambridge social enterprise Form the Future has strengthened its Board with the appointments of two leading figures from the ...

Executives of Oxbridge companies Darktrace, Oxford Nanopore and Oxford Science Enterprises today accompanied Chancellor ...

The East of England attracted £785.1million in venture capital investment in Q3 2025 - double the value of the previous ...

Pharmaceutical investment in the United Kingdom is approaching an inflection point, as decades of scientific strength are ...

Neuroscience company NRG Therapeutics, based at Stevenage Bioscience Catalyst, has followed its recent £50 million Series B ...